Cargando…
Novel I(1)-Imidazoline Agonist S43126 Augment Insulin Secretion in Min6 Cells
The I(1)-imidazoline receptor is a novel drug target for hypertension and insulin resistance which are major disorders associated with Type II diabetes. In the present study, we examined the effects of a novel imidazoline agonist S43126 on calcium fluxes and insulin secretion from Min6 β-cells. We a...
Autores principales: | Tesfai, Jerusalem, Crane, Louis, Baziard-Mouysset, Genevieve, Edwards, Lincoln P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944854/ https://www.ncbi.nlm.nih.gov/pubmed/27429837 http://dx.doi.org/10.4172/2155-6156.1000183 |
Ejemplares similares
-
Imidazoline-I2 PET Tracers in Neuroimaging
por: Parker, Christine A., et al.
Publicado: (2023) -
Identification of an imidazoline binding protein: Creatine kinase and an imidazoline-2 binding site
por: Kimura, Atsuko, et al.
Publicado: (2009) -
Insulin secretion assays in an engineered MIN6 cell line
por: Yang, Liu, et al.
Publicado: (2023) -
Simvastatin Impairs Insulin Secretion by Multiple Mechanisms in MIN6 Cells
por: Yaluri, Nagendra, et al.
Publicado: (2015) -
Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells
por: Ning, Y, et al.
Publicado: (2008)